Portsmouth, VA -- (SBWire) -- 03/21/2016 --ResearchPeptides.com, one of the world's leading peptide online forums and guides, reveals that IGF 1 or Insulin-like growth factor 1 also known as the somatomedin C is currently undergoing several studies and researches to determine its possible benefits in dealing with life-threatening diseases such as cancer, tumor and diabetes. The IGF 1 is a type of protein embedded in the human body. The molecular structure of IGF 1 is quite similar to the molecular structure insulin. According to ResearchPeptides.com, the IGF 1 plays a huge part in the development of a child and it continuously plays an important role in the muscle growth and development of adults.
In a study being conducted by Dr. Jaime Guevarra-Aguirre, an endocrinologist studying the Laron population with the longevity specialist Dr. Valter Longo, the two revealed a wonderful development and breakthrough after several years of continuous research and study. For over 30 years, Dr. Jaime Guevarra-Aguirre visits southern Ecuador where a third of the population of individuals with Laron syndrome lives. All of the individuals experiencing Laron syndrome came from one ancestor who introduced the mutated genes.
Laron syndrome is far different from dwarfism. Though the physical appearance of persons with Laron syndrome and dwarfism are quite similar, the former doesn't lack growth hormone. Laron syndrome causes a defect in the receptors found in the liver that is expected to connect to the bodily hormones and produce the IGF 1. As a result, the person with IGF 1 can't grow taller than 4 feet. Aside from that, the persons with Laron syndrome are healthy and their life span is relatively longer than those who experiences dwarfism. But, because of the absence of IGF 1, it can also prevent the development of cells that can lead to cancer and diabetes.
Due to the positive effects of controlling the growth of IGF 1 in mice, Dr. Jaime Guevarra-Aguirre and Dr. Valter Longo conducts research and study to develop a medicine that would block IGF 1 in humans. The research continues to push through. However, Dr. Jaime Guevarra-Aguirre and Dr. Valter Longo reveals that the answer regarding the effectiveness of the medicine that blocks IGF 1 can take up to a decade. In connection with this ResearchPeptides.com informs the general public about the update and news regarding the development of the research being conducted by Dr. Jaime Guevarra-Aguirre and Dr. Valter Longo.
About Researchpeptides.com
Researchpeptides.com is a blog or a forum website where people can learn and share their views about specific topics and all its other important aspects. Interested people should sign up and create a publicly viewable profile. The forum provides verified topic discussions from all its members for the purpose of research.
Contact:
Dimitry Vital
PR and Marketing @ Research Peptides Forum
Telephone: 757-394-2311
Website: http://www.researchpeptides.com
